Core A: Administrative and Biostatistics Core
核心 A:行政和生物统计学核心
基本信息
- 批准号:10685637
- 负责人:
- 金额:$ 20.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvisory CommitteesAntineoplastic AgentsAuthorshipBiologicalBiological AssayBiometryBiostatistics CoreBudgetsChemicalsChicagoCollaborationsCyanobacteriumDataData DisplayDatabasesDependenceDevelopmentDisputesDrug KineticsEffectivenessEnsureEvaluationFosteringGoalsGrantHousingIllinoisIndustrializationInformation DisseminationInformation ServicesInstitutionInvestigationLaboratoriesLeadershipLichen - organismMalignant NeoplasmsMethodsModelingMoldsNorth CarolinaOccupational activity of managing financesOhioOrganization administrative structuresPersonsPharmaceutical ChemistryPharmacologic SubstancePlantsProgram EffectivenessProgram EfficiencyProgram Research Project GrantsProviderResearchResearch PersonnelResearch Project GrantsResourcesScientistStatistical MethodsStructureTeleconferencesTelephoneTimeTrainingUniversitiesValidationVisualWorkchemotherapeutic agentcomputerized data processingdesignexperimental analysisexperimental studyfungusmeetingsmembermultidimensional datanoveloperationpreservationprogramssymposiumtumor
项目摘要
PROJECT SUMMARY – ADMINISTRATIVE AND BIOSTATISTICS CORE (CORE A)
The overall goals of the Administrative and Biostatistics Core (Core A) are to 1) continue to provide a structure
to facilitate effective interactions toward the accomplishment of the aims of this Program Project and specifically
to foster and promote the goals of the Program and each component (cores and projects) by providing scientific
direction, administrative and budgetary support, oversight, integration of program activities and the industrial
partner, and ensuring operational efficiency; and 2) to continue to provide biostatistics and other statistical
support for the P01. The following are the objectives of Core A: 1) provide research direction by setting the
research agenda focused on the discovery of novel chemicals from selected tropical rainforest plants, as well as
lichens, cyanobacteria and filamentous fungi, for development as cancer chemotherapeutic agents, particularly
for tumors not cured by present treatment methods. 2) Ensure operational efficiency for Program components
by providing centralized grant administration, information dissemination, budget data processing, and exchange
of information and services. 3) Promote integration of the Research Projects and Cores to promote interaction
among the three primary universities represented by the investigators, and relevant external entities and 4)
provide biostatistics support for the three Projects and the two Cores of the P01 Program. Core A will continue
to ensure that all components of the Program work seamlessly together to accomplish the overall and specific
project goals of the P01 Program.
项目摘要 – 行政和生物统计核心(核心 A)
行政和生物统计核心(核心 A)的总体目标是 1) 继续提供一个结构
促进有效的互动,以实现本计划项目的目标,特别是
通过提供科学的信息,促进和促进该计划及其每个组成部分(核心和项目)的目标
指导、行政和预算支持、监督、方案活动和工业界的整合
合作伙伴,并确保运营效率;以及 2) 继续提供生物统计和其他统计数据
对 P01 的支持如下是核心 A 的目标: 1)通过设定提供研究方向。
研究议程侧重于从选定的热带雨林植物中发现新型化学物质,以及
地衣、蓝细菌和丝状真菌,用于开发癌症化疗剂,特别是
针对目前治疗方法未治愈的肿瘤 2) 确保计划组成部分的运行效率。
通过提供集中的赠款管理、信息传播、预算数据处理和交换
3)促进研究项目和核心的整合,促进互动。
调查人员代表的三所小学和相关外部实体以及 4)
将继续为 P01 计划的三个项目和两个核心提供生物统计支持。
确保该计划的所有组成部分无缝地协同工作,以完成总体和具体的目标
P01 计划的项目目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alan Douglas Kinghorn其他文献
Alan Douglas Kinghorn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alan Douglas Kinghorn', 18)}}的其他基金
Development of novel therapeutics for a neglected tropical disease leishmaniasis
开发新疗法治疗被忽视的热带疾病利什曼病
- 批准号:
8047041 - 财政年份:2010
- 资助金额:
$ 20.23万 - 项目类别:
DEVELOPING NEW SOURCES OF ANTICANCER DRUGS: ENDEMIC COASTAL MACROLICHENS AND THEIR ASCOMYCETES AND BASIDIOMYCETES MYCOBIONTS
开发抗癌药物新来源:地方性沿海大地衣及其子囊菌和担子菌菌体
- 批准号:
9440799 - 财政年份:2007
- 资助金额:
$ 20.23万 - 项目类别:
Discovery of Anticancer Agents of Diverse Natural Orgin
多种天然来源的抗癌剂的发现
- 批准号:
7921386 - 财政年份:2007
- 资助金额:
$ 20.23万 - 项目类别:
Discovery of Anticancer Agents of Diverse Natural Origin
多种天然来源的抗癌剂的发现
- 批准号:
10524068 - 财政年份:2007
- 资助金额:
$ 20.23万 - 项目类别:
Discovery of Anticancer Agents of Diverse Natural Origin
多种天然来源的抗癌剂的发现
- 批准号:
9268410 - 财政年份:2007
- 资助金额:
$ 20.23万 - 项目类别:
Extraction, Dereplication, Isolation Chemistry, and Biological Evaluation
提取、去重复、分离化学和生物学评估
- 批准号:
7302061 - 财政年份:2007
- 资助金额:
$ 20.23万 - 项目类别:
Isolation Chemistry of Tropical Plants and Biological Evaluation
热带植物的分离化学和生物学评价
- 批准号:
8608727 - 财政年份:2007
- 资助金额:
$ 20.23万 - 项目类别:
Discovery of Anticancer Agents of Diverse Natural Origin
多种天然来源的抗癌剂的发现
- 批准号:
8865564 - 财政年份:2007
- 资助金额:
$ 20.23万 - 项目类别:
Isolation Chemistry of Tropical Plants and Biological Evaluation
热带植物的分离化学和生物学评价
- 批准号:
9268416 - 财政年份:2007
- 资助金额:
$ 20.23万 - 项目类别:
Core A: Administrative and Biostatistics Core
核心 A:行政和生物统计学核心
- 批准号:
10621886 - 财政年份:2007
- 资助金额:
$ 20.23万 - 项目类别:
相似海外基金
Investigating mitochondrial dysfunction in high-risk prostate cancer
研究高危前列腺癌中的线粒体功能障碍
- 批准号:
10570345 - 财政年份:2023
- 资助金额:
$ 20.23万 - 项目类别:
Defining kinase interaction pathways to enhance anti-cancer efficacy and minimize associated morbidities of kinase inhibitor drugs.
定义激酶相互作用途径,以增强抗癌功效并最大限度地减少激酶抑制剂药物的相关发病率。
- 批准号:
10644554 - 财政年份:2023
- 资助金额:
$ 20.23万 - 项目类别:
A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer
开发分子标记来预测非小细胞肺癌免疫靶向药物反应的多模式方法
- 批准号:
10228710 - 财政年份:2018
- 资助金额:
$ 20.23万 - 项目类别:
2/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education
2/2:UHCOP-DLDCCC 联盟:癌症药物发现/开发和教育
- 批准号:
9789842 - 财政年份:2018
- 资助金额:
$ 20.23万 - 项目类别:
Defining the Biological and Mechanistic Implications of XPO1 Mutations in Hematologic Malignancies
定义 XPO1 突变在血液系统恶性肿瘤中的生物学和机制意义
- 批准号:
10333411 - 财政年份:2018
- 资助金额:
$ 20.23万 - 项目类别: